Literature DB >> 16520776

Pathogenesis of HIV infection: what the virus spares is as important as what it destroys.

Zvi Grossman1, Martin Meier-Schellersheim, William E Paul, Louis J Picker.   

Abstract

Upon transmission to a new host, HIV targets CCR5+ CD4+ effector memory T cells, resulting in acute, massive depletion of these cells from mucosal effector sites. This depletion does not initially compromise the regenerative capacity of the immune system because naive and most central memory T cells are spared. Here, we discuss evidence suggesting that frequent activation of these spared cells during the chronic phase of HIV infection supplies mucosal tissues with short-lived CCR5+ CD4+ effector cells that prevent life-threatening infections. This immune activation also facilitates continued viral replication, but infection and killing of target T cells by HIV are selective and the impact on effector-cell lifespan is limited. We propose, however, that persistent activation progressively disrupts the functional organization of the immune system, reducing its regenerative capacity and facilitating viral evolution that leads to loss of the exquisite target cell-sparing selectivity of viral replication, ultimately resulting in AIDS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16520776     DOI: 10.1038/nm1380

Source DB:  PubMed          Journal:  Nat Med        ISSN: 1078-8956            Impact factor:   53.440


  189 in total

Review 1.  The role of cytokines in the pathogenesis and treatment of HIV infection.

Authors:  Marta Catalfamo; Cecile Le Saout; H Clifford Lane
Journal:  Cytokine Growth Factor Rev       Date:  2012-06-26       Impact factor: 7.638

Review 2.  New insights for FOXO and cell-fate decision in HIV infection and HIV associated neurocognitive disorder.

Authors:  Min Cui; Yunlong Huang; Yong Zhao; Jialin Zheng
Journal:  Adv Exp Med Biol       Date:  2009       Impact factor: 2.622

Review 3.  Th17 cell dynamics in HIV infection.

Authors:  Nichole R Klatt; Jason M Brenchley
Journal:  Curr Opin HIV AIDS       Date:  2010-03       Impact factor: 4.283

4.  The CD8+ HLA-DR+ T cells expanded in HIV-1 infection are qualitatively identical to those from healthy controls.

Authors:  Hiromi Imamichi; Richard A Lempicki; Joseph W Adelsberger; Rebecca B Hasley; Alice Rosenberg; Gregg Roby; Catherine A Rehm; Amy Nelson; Sonya Krishnan; Mark Pavlick; Christian J Woods; Michael W Baseler; H Clifford Lane
Journal:  Eur J Immunol       Date:  2012-08-06       Impact factor: 5.532

5.  CD4+ T cell-dependent and CD4+ T cell-independent cytokine-chemokine network changes in the immune responses of HIV-infected individuals.

Authors:  Kelly B Arnold; Gregory L Szeto; Galit Alter; Darrell J Irvine; Douglas A Lauffenburger
Journal:  Sci Signal       Date:  2015-10-20       Impact factor: 8.192

6.  The well-tempered SIV infection: Pathogenesis of SIV infection in natural hosts in the wild, with emphasis on virus transmission and early events post-infection that may contribute to protection from disease progression.

Authors:  Kevin Raehtz; Ivona Pandrea; Cristian Apetrei
Journal:  Infect Genet Evol       Date:  2016-07-06       Impact factor: 3.342

Review 7.  The role of HIV-1 Vpr in promoting the infection of nondividing cells and in cell cycle arrest.

Authors:  Hamayun J Sharifi; Andrea M Furuya; Carlos M C de Noronha
Journal:  Curr Opin HIV AIDS       Date:  2012-03       Impact factor: 4.283

Review 8.  Role of immune activation in HIV pathogenesis.

Authors:  Peter W Hunt
Journal:  Curr HIV/AIDS Rep       Date:  2007-02       Impact factor: 5.071

9.  Altered balance between Th17 and Th1 cells at mucosal sites predicts AIDS progression in simian immunodeficiency virus-infected macaques.

Authors:  V Cecchinato; C J Trindade; A Laurence; J M Heraud; J M Brenchley; M G Ferrari; L Zaffiri; E Tryniszewska; W P Tsai; M Vaccari; R Washington Parks; D Venzon; D C Douek; J J O'Shea; G Franchini
Journal:  Mucosal Immunol       Date:  2008-05-07       Impact factor: 7.313

Review 10.  Coinfecting viruses as determinants of HIV disease.

Authors:  Andrea Lisco; Christophe Vanpouille; Leonid Margolis
Journal:  Curr HIV/AIDS Rep       Date:  2009-02       Impact factor: 5.071

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.